See more : Zuora, Inc. (0XL5.L) Income Statement Analysis – Financial Results
Complete financial analysis of Brilliant Acquisition Corporation (BRLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brilliant Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
You may be interested
- Custom Truck One Source, Inc. (CTOS-WT) Income Statement Analysis – Financial Results
- Public Joint-Stock Company “Rosseti Moscow Region” (MSRS.ME) Income Statement Analysis – Financial Results
- Areeya Property Public Company Limited (A.BK) Income Statement Analysis – Financial Results
- ABV Consulting, Inc. (ABVN) Income Statement Analysis – Financial Results
- Chubu Shiryo Co., Ltd. (2053.T) Income Statement Analysis – Financial Results
Brilliant Acquisition Corporation (BRLI)
Industry: Shell Companies
Sector: Financial Services
About Brilliant Acquisition Corporation
Brilliant Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2019 and is based in Shanghai, China.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.20M | 670.92K | 148.01K | 0.00 |
| Gross Profit | -1.20M | -670.92K | -148.01K | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.20K | 670.92 | 148.01 | 35.42 |
| Other Expenses | 1.20M | 670.92K | 148.01K | 0.00 |
| Operating Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
| Cost & Expenses | 1.20M | 670.92K | 148.01K | 35.42 |
| Interest Income | 64.95K | 4.63K | 3.06K | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -169.84K | -67.16K | 172.79K | 171.86K |
| EBITDA | -1.37M | -670.92K | 24.78K | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.20M | -670.92K | -148.01K | -35.42 |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 234.79K | 71.79K | -169.73K | 0.00 |
| Income Before Tax | -967.61K | -599.13K | -317.74K | -35.42 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -234.79K | -4.63K | -3.06K | 0.00 |
| Net Income | -732.83K | -594.49K | -314.68K | -35.42 |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.16 | -0.10 | -0.09 | 0.00 |
| EPS Diluted | -0.16 | -0.10 | -0.09 | 0.00 |
| Weighted Avg Shares Out | 4.64M | 6.11M | 3.70M | 0.00 |
| Weighted Avg Shares Out (Dil) | 4.64M | 6.11M | 3.70M | 0.00 |
360 Financial Inc. Invests $47,000 in Opko Health Inc. (NASDAQ:OPK)
360 Financial Inc. purchased a new stake in Opko Health Inc. (NASDAQ:OPK) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 28,754 shares of the biotechnology company’s stock, valued at...
Phillip Md Et Al Frost Acquires 200,000 Shares of Opko Health Inc. (NASDAQ:OPK) Stock
Opko Health Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost purchased 200,000 shares of the company’s stock in a transaction that occurred on Thursday, March 26th. The stock was acquired at an average cost of $1.38 per share, with a...
Opko Health Inc. (NASDAQ:OPK) Position Trimmed by Bank of Montreal Can
Bank of Montreal Can decreased its holdings in shares of Opko Health Inc. (NASDAQ:OPK) by 88.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 65,283...
$215.93 Million in Sales Expected for Opko Health Inc. (NASDAQ:OPK) This Quarter
Equities analysts expect Opko Health Inc. (NASDAQ:OPK) to report sales of $215.93 million for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Opko Health’s earnings. The highest sales estimate is $216.20 million and the...
OPKO's BioReference Laboratories Widens COVID-19 Testing (Revised)
OPKO's (OPK) subsidiary, BioReference Laboratories, collaborates with the City of Detroit to offer COVID-19 testing.
OPKO's BioReference Laboratories Offers COVID-19 Testing (Revised)
OPKO's (OPK) BioReference Laboratories will initially provide testing for facilities at Burlington, Essex, Hudson, Ocean and Union Counties in New Jersey.
OPKO's BioReference Laboratories Widens COVID-19 Testing
OPKO's (OPK) subsidiary, BioReference Laboratories, collaborates with the City of Detroit to offer COVID-19 testing.
Opko Health Inc. (NASDAQ:OPK) Shares Sold by ProShare Advisors LLC
ProShare Advisors LLC cut its stake in shares of Opko Health Inc. (NASDAQ:OPK) by 5.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 196,205 shares of the biotechnology company’s stock after selling...
Prudential Financial Inc. Sells 76,248 Shares of Opko Health Inc. (NASDAQ:OPK)
Prudential Financial Inc. lowered its stake in shares of Opko Health Inc. (NASDAQ:OPK) by 11.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 602,008 shares of the biotechnology company’s...
OPKO's BioReference Laboratories Offers COVID-19 Testing
OPKO's (OPK) BioReference Laboratories will initially provide testing for facilities at Burlington, Essex, Hudson, Ocean and Union Counties in New Jersey.
Source: https://incomestatements.info
Category: Stock Reports